Please login to the form below

Not currently logged in
Email:
Password:

Sanofi earmarks €170m for new French vaccines facility

Will expand its Val de Reuil production unit

Sanofi

French pharmaceutical company Sanofi has invested €170m to expand its existing vaccine production operations in northern France.

The new Val de Reuil facility will allow Sanofi Pasteur to increase supply of its new quadrivalent influenza vaccine VaxigripTetra.

Philippe Luscan, executive vice president, global industrial affairs, Sanofi, said: “Our investment underlines Sanofi’s intent to strengthen our industrial capacities in France as a major centre of influenza vaccines production for worldwide markets.”

Sanofi - who has made several investments to improve and expand its vaccine production capabilities - plans to complete the expansion by 2021, and will begin producing vaccines in the new facility in 2022.

David Loew, executive vice president, Sanofi, said: “Influenza continues to be a major public health problem around the world, causing serious complications, hospitalisations and deaths, mostly for certain high-risk individuals.

“As a global leader in flu vaccines, this expansion reinforces Sanofi Pasteur’s ability to tackle this underestimated health challenge.”

Article by
Gemma Jones

17th October 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics